Boosting pharma in Europe: Lilly’s $3bn facility signals major confidence in EU manufacturing

EU PERSPECTIVES - Eli Lilly and Company's decision to invest $3bn (€2.6bn) in a next-generation manufacturing site in Katwijk, the Netherlands, offers a counterpoint to the prevailing narrative of Europe losing ground in the global pharmaceutical race. Read more

Lilly aims to boost weight-loss pill production in Europe. SOURCE: Eli Lilly and Company